ライフサイエンスコーパス: vaccine preparation

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 future development of diagnostic assays and vaccine preparations.

2 fied and/or contaminating TLR ligands in PPS vaccine preparations.

3 prove to be essential components of malaria vaccine preparations.

4 e of such strains or synthetic constructs in vaccine preparations.

5 One vaccine preparation also contained cells transduced with

6 0 (40 participants); as a control, a placebo vaccine preparation also was administered (10 participan

7 l pathogenesis and host protective immunity, vaccine preparation and characteristics, stimulated host

8 lecules, exosomes may also have potential in vaccine preparations and as diagnostic markers.

9 nd that immunization of rabbits with an rD15 vaccine preparation conferred partial protection against

10 HER-2/neu-overexpressing cancers received a vaccine preparation consisting of putative HER-2/neu hel

11 Previously, we showed that a vaccine preparation containing the native hemoglobin rec

12 ce with formalin-inactivated influenza virus vaccine preparations containing disparate HA and NA prot

13 ogic materials that come in contact with the vaccine preparation during production to prevent the int

14 more, inclusion of NA in addition to HA in a vaccine preparation for chickens may not enhance the hig

15 nactivated respiratory syncytial virus (RSV) vaccine preparations have been shown to cause enhanced d

16 uce the logistical demands of using separate vaccine preparations in the field.

17 Current dendritic cell (DC) vaccine preparations involving ex vivo differentiation a

18 5) vectors both expressing Ag85A in a single vaccine preparation is able to reduce anti-vector immuni

19 The incorporation of such peptides into vaccine preparations may enhance the efficacy of vaccine

20 acterial proteins through their inclusion in vaccine preparations must continue to be pursued.

21 een treated clinically with crude or defined vaccine preparations or cytokines, such as IFN-gamma and

22 nt out the importance of cell substrates for vaccine preparation since the virus may change during pa

23 prior infection and 2 Aspergillus fumigatus vaccine preparations (sonicate and filtrate) administere

24 aride (LPS) and assessed the ability of each vaccine preparation to protect mice against pulmonary ch

25 evelopment of a standardized anti-RNP T cell vaccine preparation useful for multiple patients.

26 rticipants and study staff not involved with vaccine preparation were masked to the randomisation gro

27 terns of mutations present at a low level in vaccine preparations were characteristic of seed viruses

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。